BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27083573)

  • 1. DNA methylation dynamics in human induced pluripotent stem cells.
    Nishino K; Umezawa A
    Hum Cell; 2016 Jul; 29(3):97-100. PubMed ID: 27083573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation dynamics in human induced pluripotent stem cells over time.
    Nishino K; Toyoda M; Yamazaki-Inoue M; Fukawatase Y; Chikazawa E; Sakaguchi H; Akutsu H; Umezawa A
    PLoS Genet; 2011 May; 7(5):e1002085. PubMed ID: 21637780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic memory in induced pluripotent stem cells.
    Kim K; Doi A; Wen B; Ng K; Zhao R; Cahan P; Kim J; Aryee MJ; Ji H; Ehrlich LI; Yabuuchi A; Takeuchi A; Cunniff KC; Hongguang H; McKinney-Freeman S; Naveiras O; Yoon TJ; Irizarry RA; Jung N; Seita J; Hanna J; Murakami P; Jaenisch R; Weissleder R; Orkin SH; Weissman IL; Feinberg AP; Daley GQ
    Nature; 2010 Sep; 467(7313):285-90. PubMed ID: 20644535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere dynamics in human pluripotent stem cells.
    Ma B; Martínez P; Sánchez-Vázquez R; Blasco MA
    Cell Cycle; 2023; 22(23-24):2505-2521. PubMed ID: 38219218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic and Transcriptional Shifts in Human Neural Stem Cells after Reprogramming into Induced Pluripotent Stem Cells and Subsequent Redifferentiation.
    Haubenreich C; Lenz M; Schuppert A; Peitz M; Koch P; Zenke M; Brüstle O
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete reprogramming of DNA replication timing in induced pluripotent stem cells.
    Edwards MM; Wang N; Massey DJ; Bhatele S; Egli D; Koren A
    Cell Rep; 2024 Jan; 43(1):113664. PubMed ID: 38194345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation alterations in iPSC- and hESC-derived neurons: potential implications for neurological disease modeling.
    de Boni L; Gasparoni G; Haubenreich C; Tierling S; Schmitt I; Peitz M; Koch P; Walter J; Wüllner U; Brüstle O
    Clin Epigenetics; 2018; 10():13. PubMed ID: 29422978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced Pluripotent Stem Cell Differentiation and Three-Dimensional Tissue Formation Attenuate Clonal Epigenetic Differences in Trichohyalin.
    Petrova A; Capalbo A; Jacquet L; Hazelwood-Smith S; Dafou D; Hobbs C; Arno M; Farcomeni A; Devito L; Badraiq H; Simpson M; McGrath JA; Di WL; Cheng JB; Mauro TM; Ilic D
    Stem Cells Dev; 2016 Sep; 25(18):1366-75. PubMed ID: 27460132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine-derived cells provide a readily accessible cell type for feeder-free mRNA reprogramming.
    Gaignerie A; Lefort N; Rousselle M; Forest-Choquet V; Flippe L; Francois-Campion V; Girardeau A; Caillaud A; Chariau C; Francheteau Q; Derevier A; Chaubron F; Knöbel S; Gaborit N; Si-Tayeb K; David L
    Sci Rep; 2018 Sep; 8(1):14363. PubMed ID: 30254308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies.
    Nath SC; Menendez L; Friedrich Ben-Nun I
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced Tissue-Specific Stem Cells and Epigenetic Memory in Induced Pluripotent Stem Cells.
    Noguchi H; Miyagi-Shiohira C; Nakashima Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel epigenetic clock for fetal brain development predicts prenatal age for cellular stem cell models and derived neurons.
    Steg LC; Shireby GL; Imm J; Davies JP; Franklin A; Flynn R; Namboori SC; Bhinge A; Jeffries AR; Burrage J; Neilson GWA; Walker EM; Perfect LW; Price J; McAlonan G; Srivastava DP; Bray NJ; Cope EL; Jones KM; Allen ND; Pishva E; Dempster EL; Lunnon K; Mill J; Hannon E
    Mol Brain; 2021 Jun; 14(1):98. PubMed ID: 34174924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent stem cells with low differentiation potential contain incompletely reprogrammed DNA replication.
    Paniza T; Deshpande M; Wang N; O'Neil R; Zuccaro MV; Smith ME; Madireddy A; James D; Ecker J; Rosenwaks Z; Egli D; Gerhardt J
    J Cell Biol; 2020 Sep; 219(9):. PubMed ID: 32673399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Democracy derived? New trajectories in pluripotent stem cell research.
    Scott CT; McCormick JB; DeRouen MC; Owen-Smith J
    Cell; 2011 Jun; 145(6):820-6. PubMed ID: 21663787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of non-integrating reprogramming methods.
    Schlaeger TM; Daheron L; Brickler TR; Entwisle S; Chan K; Cianci A; DeVine A; Ettenger A; Fitzgerald K; Godfrey M; Gupta D; McPherson J; Malwadkar P; Gupta M; Bell B; Doi A; Jung N; Li X; Lynes MS; Brookes E; Cherry AB; Demirbas D; Tsankov AM; Zon LI; Rubin LL; Feinberg AP; Meissner A; Cowan CA; Daley GQ
    Nat Biotechnol; 2015 Jan; 33(1):58-63. PubMed ID: 25437882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Plant-Made Fibroblast Growth Factor for Human Pluripotent Stem Cells.
    Jia J; Wilson W; Karmaker A; Nishimura A; Otsuka H; Ohara K; Okawa H; McDonald K; Nandi S; Albeck JG; Rodriguez R; Zhou P; Nolta JA
    Stem Cells Dev; 2024 Feb; 33(3-4):57-66. PubMed ID: 38062993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of IPi001-A/B/C human induced pluripotent stem cell lines from healthy amniotic fluid cells.
    Boullé M; Boucharlat A; Leleu A; Banal C; Coussement A; Hollenstein M; Yates F; Lefort N; Agou F
    Stem Cell Res; 2024 Apr; 76():103350. PubMed ID: 38387169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluation of the safety of induced pluripotent stem cells: a call from somatic mosaicism.
    Liu W; Li M; Qu J; Yi F; Liu GH
    Protein Cell; 2013 Feb; 4(2):83-5. PubMed ID: 23264042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells.
    Ohm JE; Mali P; Van Neste L; Berman DM; Liang L; Pandiyan K; Briggs KJ; Zhang W; Argani P; Simons B; Yu W; Matsui W; Van Criekinge W; Rassool FV; Zambidis E; Schuebel KE; Cope L; Yen J; Mohammad HP; Cheng L; Baylin SB
    Cancer Res; 2010 Oct; 70(19):7662-73. PubMed ID: 20841480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapamycin mediated caspase 9 homodimerization to safeguard human pluripotent stem cell therapy].
    Yang Y; Liu Y; Chen M; Li S; Lu X; He Y; Zhang K; Zou Q
    Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):4098-4107. PubMed ID: 37877393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.